Tradition Wealth Management, LLC Geron Corp Transaction History

Tradition Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $492 - $922	-250 Reduced 11.11%	2,000 $6,000
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $535 - $850	250 Added 12.5%	2,250 $5,000
Q1 2022 May 11, 2022	BUY	$0.99 - $1.6 $1,980 - $3,200	2,000 New	2,000 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $2,440 - $3,440	-2,000 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$1.25 - $1.83 $2,500 - $3,660	2,000 New	2,000 $3,000
Q1 2021 May 14, 2021	SELL	$1.52 - $2.1 $3,040 - $4,200	-2,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $3,100 - $4,100	2,000 New	2,000 $3,000

306

452M

1.07M

648K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $688M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradition Wealth Management, LLC with notifications on news.